Therapeutic interventions for vascular depression: a systematic review (Q37970618)

26 August 2017

Therapeutic interventions for vascular depression: a systematic review (English)

1 reference

26 August 2017

1 reference

André Russowsky Brunoni

series ordinal

1

1 reference

26 August 2017

Isabela Martins Benseñor

series ordinal

2

1 reference

PubMed ID

22189931

26 August 2017

Tania Correa de Toledo Ferraz Alves

series ordinal

3

1 reference

26 August 2017

1 December 2011

1 reference

Brazilian Journal of Psychiatry

26 August 2017

1 reference

26 August 2017

33

1 reference

26 August 2017

4

1 reference

26 August 2017

400-409

1 reference

Vascular factors and depression

26 August 2017

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Prevalence of depression in adults with diabetes. An epidemiological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Relationships between depressive symptoms, anxiety, alcohol consumption, and blood pressure: results from the CARDIA Study. Coronary Artery Risk Development in Young Adults Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Depression and vascular disease: what is the relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

'Vascular depression' hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Clinically defined vascular depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Distinguishing between the validity and utility of psychiatric diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

The vascular depression subtype: evidence of internal validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Vascular depression: A distinct diagnostic subtype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Vascular depression: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Systematic review of the depressive symptoms associated with vascular conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Is there improvement of "vascular depression" after carotid artery stent placement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Brain white-matter hyperintensities and treatment outcome in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Cerebrovascular reactivity in depressed patients without vascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

White matter hyperintensities in late life depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Is poststroke depression a vascular depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

The associations of high levels of C-reactive protein with depression and myocardial infarction in 9258 women and men from the HUNT population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Hypertension and cerebral diffusion tensor imaging in small vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Probability of stroke: a risk profile from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400015

10.1590/S1516-44462011000400015

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22189931